Applications of Butyrylcholine Iodide in Industrial Manufacturing

Butyrylcholine Iodide serves as a specialized intermediate and analytical standard in several industrial production sectors. Below, we outline primary downstream applications, focusing on distinctive compliance protocols, process stages, and end-use product profiles for each segment.

1. Pharmaceutical API Reference Standards Production

Pharmaceutical laboratories and manufacturers consistently utilize Butyrylcholine Iodide as a certified reference compound for the quantitative determination of cholinesterase activity assays during drug development and routine quality control. Our facility supplies this product under controlled synthesis and full analytical documentation to meet documentation and reproducibility needs in regulated environments.

Industry compliance standards

• USP Compendial Reference Standards for Assay (United States Pharmacopeia)
• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• WHO Good Laboratory Practice (GLP) Guidelines
• European Pharmacopoeia (Ph. Eur.) assay method requirements

Typical usage ratio

• Reference concentrations range from 100 μg/mL to 1 mg/mL, strictly determined by assay protocol and validation study requirements.

Downstream process integration

• Integrates in the analytical testing workflow, added to the test solution during cholinesterase activity assessment or as a calibration standard for apparatus validation in QC laboratories.

Final product types

• Validated reference solutions
• Pharmaceutical method control panels
• Proficiency test kits for quality assurance
• Calibrators used in API release testing

2. Clinical Diagnostic Reagent Manufacturing

Butyrylcholine Iodide is a critical raw material in the industrial synthesis of enzyme-based reagents used in in-vitro cholinesterase quantification kits. Diagnostic manufacturers depend on this input to ensure reliable, traceable measurement of pseudocholinesterase activity in human serum, with product purity directly affecting patient result accuracy.

Industry compliance standards

• ISO 13485 Quality Systems for Medical Devices
• IVD Directive 98/79/EC for Diagnostic Medical Devices (Europe)
• FDA 21 CFR 820 for Medical Device Quality System Regulation
• CLIA (Clinical Laboratory Improvement Amendments) reagent validation

Typical usage ratio

• Formulation requires 0.15 – 0.4 mg/mL in ready-to-use working buffer, depending on target enzyme activity and sensitivity profiles in commercial reagent lots.

Downstream process integration

• Introduced during reagent blending and buffer preparation, prior to lyophilization or packaging into single-use clinical diagnostic test vials.

Final product types

• Cholinesterase colorimetric/fluorometric assay kits
• Automated clinical chemistry analyzer reagents
• Point-of-care diagnostic cartridges
• Serum enzyme screening reagent sets

3. Biochemical Research and Enzyme Activity Assay Manufacturing

University institutes and contract research organizations demand Butyrylcholine Iodide for the design, calibration, and production of enzyme activity assay systems supporting basic neurobiology and toxicology studies. Researchers incorporate the product as a defined substrate for in vitro kinetic studies of butyrylcholinesterase in animals and biofluids, tightly controlling formulation for reproducibility.

Industry compliance standards

• OECD Test Guidelines for the Testing of Chemicals
• ISO/IEC 17025 Laboratory Accreditation for Analytical Testing
• Institutional Biosafety Committee review for reagent introduction
• GLP (Good Laboratory Practice) for non-clinical research

Typical usage ratio

• Working concentrations vary from 0.05 – 2.5 mM depending on assay design, sample origin, and sensitivity required by the downstream study protocol.

Downstream process integration

• Directly dispensed into assay reaction mix, following stock solution preparation and buffer pH adjustment, with precise quantification tailored to experimental endpoint analysis.

Final product types

• Enzyme activity detection assay kits
• Substrate solutions for automated plate readers
• Pre-packaged substrate vials for university core facilities
• Research-grade biochemical screening systems

4. Veterinary Toxicology Monitoring and Antidote Research

Veterinary diagnostics laboratories and toxicology research institutes utilize Butyrylcholine Iodide in specialized assay systems, focusing on monitoring cholinesterase inhibition in animal serum due to organophosphate or carbamate exposure. The precise formulation impacts detection sensitivity critical for public health surveillance and wildlife monitoring.

Industry compliance standards

• OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals
• ISO 9001:2015 quality management for laboratory reagent production
• Association of American Feed Control Officials (AAFCO) laboratory standards
• National Veterinary Services Laboratories (NVSL, USDA, USA) standards for enzyme assays

Typical usage ratio

• Reagent mixtures typically contain 0.10 – 0.50 mM of the raw material, with adjustment based on required detection limits for individual animal species and enzyme inhibition rates.

Downstream process integration

• Formulated directly in the primary detection medium prior to running samples from field or clinical sources, often with automated delivery into testing apparatus for mass throughput screening.

Final product types

• Veterinary toxicosis test kits
• Wildlife biomonitoring assay panels
• Cholinesterase inhibition antidote validation kits
• Control reagents for veterinary diagnostic devices

5. Acetylcholinesterase Inhibitor Screening in Agrochemical R&D

Agrochemical companies and contract formulation laboratories implement Butyrylcholine Iodide as a model substrate in preclinical screening for novel acetylcholinesterase inhibitor activity. Rapid throughput platforms rely on consistently supplied, assay-grade input for reproducible kinetic measurements, directly contributing to regulatory safety dossiers and product approval construction.

Industry compliance standards

• OECD Guidelines for the Testing of Chemicals (Section 2, Effects on Biotic Systems)
• ISO 17025 certification for laboratory testing
• Good Laboratory Practice (GLP) for agrochemical development studies
• National and regional pesticide registration data requirements

Typical usage ratio

• Screening concentration varies from 0.2 – 1.0 mM, adjusted based on chemical library solubility profiles and protocol throughput demands.

Downstream process integration

• Stock solutions prepared in assay buffer and aliquoted into screening plates during lead compound evaluation campaigns, with precision dosing linked to automated liquid handling platforms.

Final product types

• High-throughput screening assay plates
• Reference substrate kits for agrochemical efficacy testing
• Lead optimization compound validation batches
• Regulatory reporting data sets for new active ingredient registration